Immune and Smooth Muscle Cells Interactions in Atherosclerosis: How to Target a Breaking Bad Dialogue?

Inflammation is a well-known pathophysiological factor of atherosclerosis but its therapeutic targeting has long been ignored. However, recent advances in the understanding of the immune mechanisms implicated in atherosclerosis have unveiled several therapeutic targets currently undergoing clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramel, Damien, Gayral, Stéphanie, Sarthou, Marie-Kerguelen, Augé, Nathalie, Nègre-Salvayre, Anne, Laffargue, Muriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882774/
https://www.ncbi.nlm.nih.gov/pubmed/31824304
http://dx.doi.org/10.3389/fphar.2019.01276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882774/
https://www.ncbi.nlm.nih.gov/pubmed/31824304
http://dx.doi.org/10.3389/fphar.2019.01276

Ejemplares similares